Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Lilly is offering single-dose vials that patients self-administer using a needle and syringe. Prices vary by dose, and the highest-strength vials are not available through the program. LillyDirect ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

The Power of Single-Dose Therapy The core innovation lies in the use of dalbavancin, an antibiotic that has demonstrated effectiveness in treating ABSSSIs with a single-dose intravenous (IV) infusion.

The pharmaceutical giant announced in August it was offering 2.5 mg and 5 mg single-dose vials of tirzepatide for the first time in response to growing demand. At the time, Lilly said the doses ...

LifeMD on Thursday said it will integrate with Eli Lilly's online pharmacy and healthcare platform to offer access to Lilly's prescription obesity treatment Zepbound in single-dose vials.

The pharmaceutical giant announced in August it was offering 2.5 mg and 5 mg single-dose vials of tirzepatide for the first time in response to growing demand. At the time, Lilly said the doses were ...

Before launching the Zepbound vials in 2024, Eli Lilly offered the drug only in a single-dose injector pen, used once weekly, in doses ranging from 2.5 mg to 15 mg. “We launched the vials last ...

Nurse hand fills syringe with medicine from glass vial. Community health concept. Vaccination programs to promote wellness. Ensuring sterile conditions and medical safety Royalty-free licenses let you ...